Oppenheimer & Co’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$169K Buy
+10,110
New +$169K ﹤0.01% 1523
2025
Q1
Sell
-10,278
Closed -$227K 1662
2024
Q4
$227K Sell
10,278
-22,124
-68% -$488K ﹤0.01% 1405
2024
Q3
$584K Buy
32,402
+13,215
+69% +$238K 0.01% 985
2024
Q2
$312K Buy
19,187
+5,665
+42% +$92.1K ﹤0.01% 1176
2024
Q1
$191K Buy
13,522
+1,180
+10% +$16.7K ﹤0.01% 1350
2023
Q4
$129K Sell
12,342
-1,073
-8% -$11.2K ﹤0.01% 1323
2023
Q3
$137K Sell
13,415
-4,455
-25% -$45.4K ﹤0.01% 1302
2023
Q2
$135K Sell
17,870
-45,163
-72% -$340K ﹤0.01% 1332
2023
Q1
$558K Sell
63,033
-7,513
-11% -$66.5K 0.01% 899
2022
Q4
$643K Sell
70,546
-6,707
-9% -$61.2K 0.01% 837
2022
Q3
$623K Buy
77,253
+3,500
+5% +$28.2K 0.01% 815
2022
Q2
$554K Sell
73,753
-18,075
-20% -$136K 0.01% 882
2022
Q1
$861K Buy
91,828
+44,343
+93% +$416K 0.02% 797
2021
Q4
$381K Sell
47,485
-4,910
-9% -$39.4K 0.01% 1128
2021
Q3
$511K Sell
52,395
-8,890
-15% -$86.7K 0.01% 1012
2021
Q2
$606K Sell
61,285
-9,236
-13% -$91.3K 0.01% 940
2021
Q1
$814K Sell
70,521
-5,472
-7% -$63.2K 0.02% 776
2020
Q4
$734K Sell
75,993
-27,769
-27% -$268K 0.02% 749
2020
Q3
$935K Buy
103,762
+2,203
+2% +$19.9K 0.02% 613
2020
Q2
$1.25M Sell
101,559
-56,978
-36% -$702K 0.03% 497
2020
Q1
$1.43M Buy
158,537
+63,139
+66% +$568K 0.04% 425
2019
Q4
$935K Sell
95,398
-4,512
-5% -$44.2K 0.02% 642
2019
Q3
$687K Sell
99,910
-13,571
-12% -$93.3K 0.02% 694
2019
Q2
$1.05M Sell
113,481
-4,275
-4% -$39.4K 0.03% 582
2019
Q1
$1.85M Sell
117,756
-8,883
-7% -$139K 0.05% 409
2018
Q4
$1.95M Sell
126,639
-1,639
-1% -$25.3K 0.06% 344
2018
Q3
$2.76M Buy
128,278
+11,947
+10% +$257K 0.07% 308
2018
Q2
$2.83M Buy
116,331
+11,428
+11% +$278K 0.08% 302
2018
Q1
$1.79M Sell
104,903
-18,524
-15% -$317K 0.05% 426
2017
Q4
$2.34M Sell
123,427
-27,242
-18% -$516K 0.06% 344
2017
Q3
$2.65M Buy
150,669
+5,365
+4% +$94.4K 0.07% 312
2017
Q2
$4.83M Sell
145,304
-5,147
-3% -$171K 0.13% 183
2017
Q1
$4.83M Sell
150,451
-28,760
-16% -$923K 0.14% 173
2016
Q4
$6.5M Buy
179,211
+114,902
+179% +$4.17M 0.19% 127
2016
Q3
$2.96M Sell
64,309
-50,312
-44% -$2.31M 0.09% 270
2016
Q2
$5.76M Buy
114,621
+27,774
+32% +$1.4M 0.17% 127
2016
Q1
$4.65M Sell
86,847
-4,786
-5% -$256K 0.14% 167
2015
Q4
$6.02M Sell
91,633
-26,459
-22% -$1.74M 0.18% 127
2015
Q3
$6.67M Buy
118,092
+6,182
+6% +$349K 0.2% 113
2015
Q2
$6.61M Sell
111,910
-4,524
-4% -$267K 0.18% 127
2015
Q1
$7.25M Buy
116,434
+2,270
+2% +$141K 0.2% 118
2014
Q4
$6.57M Sell
114,164
-32,561
-22% -$1.87M 0.19% 128
2014
Q3
$7.89M Sell
146,725
-6,096
-4% -$328K 0.23% 105
2014
Q2
$8.01M Buy
152,821
+2,289
+2% +$120K 0.24% 101
2014
Q1
$7.96M Buy
150,532
+11,068
+8% +$585K 0.24% 98
2013
Q4
$5.59M Buy
139,464
+13,735
+11% +$551K 0.18% 141
2013
Q3
$4.75M Buy
125,729
+2,941
+2% +$111K 0.17% 157
2013
Q2
$4.81M Buy
+122,788
New +$4.81M 0.19% 141